Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/21/17
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 09/30/23
End: 03/31/24
Due: 03/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma | NCT03143985 | Koen van Besien | user2@example.com | None | 2017-07-21 | 2022-09-01 | 2023-09-01 | - | - | 2025-07-14 |
| Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma | NCT05013437 | Koen van Besien | user2@example.com | None | 2023-09-30 | 2024-03-31 | 2025-03-31 | - | - | 2025-07-14 |